What is the preferred antibiotic and dosing for uncomplicated cystitis in a healthy non‑pregnant adult with normal renal function, and how should the regimen be adjusted for impaired renal function?

Preferred Antibiotic and Dosing for Uncomplicated Cystitis

For healthy non-pregnant adults with normal renal function, nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days is the preferred first-line agent for uncomplicated cystitis, with trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days as an equally appropriate alternative only if local resistance rates are below 20%. 1

First-Line Options for Normal Renal Function

The IDSA/ESCMID guidelines establish a clear hierarchy based on efficacy, resistance patterns, and collateral damage (ecological impact):

Primary Recommendations:

• Nitrofurantoin monohydrate/macrocrystals: 100 mg twice daily for 5 days

  • Clinical cure rate: 88-93%
  • Microbiological cure rate: 86-92%
  • Minimal resistance (<1%) and lowest propensity for collateral damage 1

• Trimethoprim-sulfamethoxazole: 160/800 mg (1 double-strength tablet) twice daily for 3 days

  • Clinical cure rate: 93%
  • Microbiological cure rate: 94%
  • Only use if local E. coli resistance is ≤20% 1
  • Alternative: Trimethoprim alone 100 mg twice daily for 3 days in some regions 1

• Fosfomycin trometamol: 3 g single dose

  • Clinical cure rate: 91%
  • Microbiological cure rate: 78-83% (notably lower than other first-line agents)
  • Minimal resistance but inferior efficacy compared to nitrofurantoin and TMP-SMX 1

The 2021 American College of Physicians guidelines and 2024 EAU guidelines confirm these same agents and durations 2, 3.

Dose Adjustments for Impaired Renal Function

Critical consideration: Nitrofurantoin effectiveness decreases significantly with declining renal function, while fosfomycin maintains efficacy.

For eGFR <60 mL/min:

• Fosfomycin 3 g single dose becomes the preferred agent

  • Clinical failure rate: 16.0% with fosfomycin vs. 23.3% with nitrofurantoin 4
  • No dose adjustment required for fosfomycin in renal impairment 5

• Avoid nitrofurantoin when eGFR <60 mL/min

  • Each 10 mL/min decrease in eGFR increases clinical failure odds by 5% (OR 1.05) 4
  • Inadequate urinary concentrations achieved with reduced renal function

For eGFR 30-60 mL/min:

• First choice: Fosfomycin 3 g single dose (no adjustment needed)
• Alternative: TMP-SMX 160/800 mg twice daily for 3 days (no adjustment needed if resistance <20%)
• Avoid: Nitrofurantoin

For eGFR <30 mL/min:

• Fosfomycin remains an option (no adjustment)
• Beta-lactams become necessary alternatives:
  • Amoxicillin-clavulanate 500/125 mg three times daily for 5-7 days
  • Cephalexin 500 mg twice daily for 5-7 days
  • Note: Beta-lactams have inferior efficacy (82% microbiological cure) and more adverse effects 1

Alternative Agents (When First-Line Cannot Be Used)

Fluoroquinolones should be reserved for other indications and NOT used for simple cystitis:

• Ciprofloxacin, levofloxacin, ofloxacin are highly efficacious in 3-day regimens (90-91% cure rates)
• However, they cause significant collateral damage (antimicrobial resistance, C. difficile risk)
• Reserve for pyelonephritis or complicated UTIs 1

Beta-lactams are second-tier alternatives:

• Amoxicillin-clavulanate, cefdinir, cefaclor, cefpodoxime-proxetil: 3-7 days
• Cephalexin: 5-7 days (less well-studied)
• Use only when nitrofurantoin, TMP-SMX, and fosfomycin cannot be used 1

Never use for empirical treatment:

• Amoxicillin or ampicillin alone (very high resistance rates worldwide) 1

Clinical Decision Algorithm

For patients with known renal function:

1. eGFR ≥60 mL/min:

   • Nitrofurantoin 100 mg BID × 5 days (preferred)
   • TMP-SMX 160/800 mg BID × 3 days (if local resistance <20%)
   • Fosfomycin 3 g × 1 dose (acceptable but slightly less effective)

2. eGFR 30-59 mL/min:

   • Fosfomycin 3 g × 1 dose (preferred)
   • TMP-SMX 160/800 mg BID × 3 days (if resistance <20%)
   • Beta-lactam alternatives if needed

3. eGFR <30 mL/min:

   • Fosfomycin 3 g × 1 dose
   • Beta-lactam (amoxicillin-clavulanate or cephalexin) × 5-7 days

For patients with unknown renal function:

• If age >65 years or risk factors for CKD: obtain eGFR before prescribing
• If young and healthy: proceed with nitrofurantoin or TMP-SMX per standard dosing

Important Caveats

• Resistance thresholds matter: The 20% resistance cutoff for TMP-SMX is based on mathematical modeling showing unacceptable clinical failure rates above this level 1
• No routine post-treatment cultures needed if symptoms resolve 3
• Retreatment: If symptoms persist or recur within 2 weeks, obtain culture and use a different antibiotic class for 7 days 3
• Men with cystitis: Use TMP-SMX 160/800 mg twice daily for 7 days (longer duration required) 3

The evidence strongly supports nitrofurantoin as the optimal first-line agent for normal renal function due to its combination of high efficacy, minimal resistance, and low ecological impact, while fosfomycin becomes essential for patients with renal impairment where nitrofurantoin loses effectiveness 4.